It is very uncertain whether summary of findings of metformin monotherapy for adults with type 2… changes all‐cause mortality compared with thiazolidinediones (very low certainty).
The review found no eligible studies for this question.
Ranolazine (monotherapy) showed no clear difference in all‐cause mortality compared with placebo (low certainty).
It is very uncertain whether external beam radiotherapy (EBRT) changes all‐cause mortality (at 1 year) compared with transarterial chemoembolisation (TACE) (very low certainty).
Ranolazine (add‐on therapy) showed no clear difference in all‐cause mortality compared with placebo (low certainty).
The review found no eligible studies for this question.
ICD plus optimal medical therapy leads to lower all‐cause mortality (HR) ‐ main analysisa 16.5 to 67.6 months compared with optimal medical therapy alone (high certainty).
The review found no eligible studies for this question.
External beam radiotherapy (EBRT) plus transarterial… may leads to lower all‐cause mortality (at maximum 1‐year compared with TACE alone (low certainty).
It is very uncertain whether summary of findings: pioglitazone monotherapy changes all‐cause mortality (N) compared with no intervention (very low certainty).
Early taxane‐based chemotherapy and androgen deprivation therapy (ADT) probably leads to lower time to death due to any cause (absolute effect size estimates based… compared with ADT only (moderate certainty).
Sildenafil citrate showed no clear difference in all‐cause mortality compared with placebo or no therapy (moderate certainty).
Tadalafil showed no clear difference in all‐cause mortality compared with placebo or no therapy (low certainty).
Interrupted showed no clear difference in all‐cause mortality compared with uninterrupted anticoagulation therapy (low certainty).